Introduction {#s1}
============

Neurotransmitters are released by Ca^2+^-triggered synaptic vesicle (SV) exocytosis, a processmediated by the SNARE complex, and regulated by synaptic proteins such as Munc18s, Munc13s, RIMs, and synaptotagmins ([@bib36]; [@bib18]). Before final fusion with the plasma membrane, SVs undergo two crucial steps: docking and priming. These processes ensure that the SVs are translocated to the plasma membrane and become fusion-competent at the active zone ([@bib35]). Defects in docking or priming produce corresponding decreases in SV exocytosis ([@bib1]; [@bib2]; [@bib33]; [@bib13]; [@bib17]). However, post-priming regulation of SV release has also been reported ([@bib31]; [@bib3]; [@bib25]). Various studies have demonstrated that Munc13-1, a protein with multiple functional domains, is required for the docking and priming ([@bib1]; [@bib2]; [@bib33]), as well as post-priming Ca^2+^-triggered SV release ([@bib4]; [@bib9]; [@bib16]). The functions of Munc13-1 in these processes are believed to be mediated by its central MUN domain, which directly interacts with syntaxin and promotes SNARE assembly ([@bib26]; [@bib41]).

Multiple domains of Munc13-1 have been implicated in regulating the MUN domain's SV priming activity ([@bib28]; [@bib40]). In mammals, four Munc13 isoforms have been identified, two of which contain an N-terminal C2A domain (Munc13-1 and ubMunc13-2) ([@bib7]; [@bib34]; [@bib5]). Betz et al. first found that the C2A domain binds to the zinc finger (ZF) domain of RIM, an active zone protein that is required for SV priming ([@bib5]). A double mutation in rat RIM2α's ZF domain (K97/99E) disrupts C2A/RIM heterodimerization ([@bib11]) and was subsequently shown to produce a large reduction in the readily releasable pool (RRP) of SVs ([@bib10]; [@bib8]), indicating that C2A binding to RIM plays an important role in SV priming. Apart from forming a heterodimer with RIM, the C2A domain also forms a homodimer, thereby promoting formation of Munc13-1 homodimers ([@bib24]). This homodimerization, however, is not necessary for SV priming and post-priming SV release ([@bib8]).

In contrast, studies in chromaffin cells have shown that a truncated Munc13-1 lacking the N-terminal C2A domain is fully able to mediate vesicle priming ([@bib5]), suggesting that the role of Munc13-1 in priming is independent of the C2A domain and its binding with RIM. Similarly, a recent study in *C. elegans* found that removing the N-terminal C2A domain from UNC-13L, a Munc13-1 homolog, does not cause a change in the size of the RRP ([@bib42]). These conflicting findings have called into doubt whether binding of the C2A domain with RIM is indeed playing a role in SV priming, prompting us to re-analyze the function of both C2A/RIM heterodimerization and C2A/C2A homodimerization using an in vivo system.

Here, we examined the functional importance of the C2A domain by generating a transgenic line of UNC-13L with a point mutation in the C2A domain (K49E) that blocks formation of C2A/C2A homodimers, and a mutant carrying two mutations in the *unc-10*/RIM ZF domain (K77/79E) that disrupts C2A/RIM heterodimer formation. We found that tonic neurotransmitter release at a low Ca^2+^ concentration and stimulus-evoked release were significantly reduced in the *unc-10*(*nu487* K77/79E) mutants, whereas SV release was normal in the UNC-13L(K49E)-rescued *unc-13* mutants. Moreover, the hypertonic sucrose-evoked responses were unaltered following disruption of homodimerization and heterodimerization, suggesting that SV priming is not determined by the state of the C2A domain. Interestingly, simultaneously disrupting C2A/C2A homodimerization in the *unc-10*(*nu487* K77/79E) mutant fully restored both tonic and evoked release. These results suggest that the synaptic transmission defect in the *unc-10*(*nu487* K77/79E) mutant is most likely caused by formation of more C2A/C2A homodimers, and that the role of UNC-10/RIM binding UNC-13 C2A domain is to release the C2A from an autoinhibitory state, allowing it to become a fusion-competent monomeric form. Finally, we show that UNC-13's C2A domain increases release probability but has little effect on SV priming.

Results {#s2}
=======

C2A/C2A homodimerization and C2A/RIM heterodimerization are conserved in *C. elegans* {#s2-1}
-------------------------------------------------------------------------------------

The UNC-13L C2A domain and the UNC-10/RIM ZF domain share high sequence identity with the corresponding domains of mouse Munc13-1 (50%) and RIM (48%) ([Figure 1A,B](#fig1){ref-type="fig"}), suggesting that UNC-13's C2A would form homo- and heterodimers in a manner similar to mouse Munc13-1. To test this idea, we directly assessed homo- and heterodimer formation by the UNC-13 C2A domain. Gel filtration analysis indicated that recombinant C2A forms a homodimer, and that this homodimerization was disrupted by a mutation (K49E) analogous to that which disrupts Munc13-1 homodimerization ([Figure 1A,C](#fig1){ref-type="fig"}) ([@bib24]; [@bib10]). To determine whether UNC-13L forms a heterodimer with UNC-10/RIM, we performed isothermal titration calorimetry (ITC) and co-immunoprecipitation experiments. Our results showed that the UNC-13L C2A domain tightly binds the UNC-10/RIM ZF domain (Kd = 1.29 µM, [Figure 1D,E](#fig1){ref-type="fig"}), and that this interaction was eliminated by a double mutation in the ZF domain (K77/79E), which is analogous to mutations that disrupt binding of the corresponding mammalian Munc13-1 and RIM domains ([Figure 1D--F](#fig1){ref-type="fig"}) ([@bib11]). Thus, our findings confirmed that UNC-13L C2A has the same two binding modes exhibited by mouse Munc13-1.

![UNC-13L exhibits conserved homodimerization and heterodimerization in *C. elegans*.\
(**A, B**) Sequence alignment of the C2A domain between worm UNC-13L and rat Munc13-1, and the zinc finger (ZF) domain between worm UNC-10 and mouse RIM1. The conserved residues in the C2A domain (K49) and the ZF domain (K77, K79) that disrupt homodimer and heterodimer formation are indicated by stars. (**C**) Separation of purified UNC-13L C2A monomer and homodimer by gel filtration. The wild-type C2A forms a homodimer that runs at 12.57 mL (blue trace, corresponding to an apparent weight of 89 kDa); this homodimer is disrupted in the monomeric UNC-13L(K49E) mutant which runs at 13.88 mL (apparent weight 52 kDa). Elution volumes of gel filtration standards are indicated underneath the plot, as follows: 11.62 mL for alcohol dehydrogenase (150 kDa), 12.85 mL for bovine serum albumin (66 kDa), and 15.45 mL for carbonic anhydrase (29 kDa), with the column void volume being 10.78 mL. (**D**) Co-immunoprecipitation (co-IP) shows that HA-LNTD (UNC-13L N-terminal domain, aa 1"605) binds wild-type FLAG-UNC-10 (aa 1--601) but not UNC-10(K77/79E) or GST. These results are representative of three independent experiments. (**E, F**) Isothermal titration calorimetry (ITC) analysis of binding of wild-type or mutated (K77/79E) UNC-10 with UNC-13L.](elife-40585-fig1){#fig1}

Disrupting C2A/RIM heterodimerization reduces mEPSCs/mIPSCs in low Ca^2+^ {#s2-2}
-------------------------------------------------------------------------

We next examined the functional roles of the C2A/C2A homodimerization and C2A/RIM heterodimerization in tonic neurotransmitter release by measuring miniature excitatory/inhibitory postsynaptic currents (mEPSCs/mIPSCs) at the neuromuscular junction. Both the mEPSCs and the mIPSCs were recorded in the presence of 0 mM and 1 mM Ca^2+^, as we have previously found that the mIPSCs are almost arrested in 0 mM Ca^2+^ but are normal 1 mM Ca^2+^ in some mutants ([@bib23]), suggesting that different Ca^2+^ concentrations should be tested to provide an accurate and thorough evaluation of tonic release. Our results showed that the mEPSCs and mIPSCs were completely abolished in the *unc-13(s69)* null mutant, and were fully restored by neuronal expression of full-length UNC-13L ([Figure 2](#fig2){ref-type="fig"}). Deleting the C2A domain (UNC-13LΔC2A) significantly decreased mEPSC frequency in both 0 mM and 1 mM Ca^2+^ ([Figure 2B,E](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}), demonstrating an important role of the C2A domain in tonic acetylcholine (ACh) release. The mIPSC frequency was significantly decreased in the UNC-13LΔC2A rescue animals in 0 mM Ca^2+^ ([Figure 2C](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}), but was unchanged in 1 mM Ca^2+^, compared to that in the UNC-13L rescue animals ([Figure 2F](#fig2){ref-type="fig"}). Thus, the UNC-13L C2A domain is important for tonic release of both ACh and GABA; however, the requirement for C2A in GABA release can be bypassed by the presence of extracellular calcium, presumably because of increased release probability. The differential impact of deleting C2A on ACh and GABA release in 1 mM Ca^2+^ could reflect differences in release probability at these two types of synapses ([@bib23]). In fact, SV release from inhibitory synapses displays a higher release probability than excitatory synapses in the mammalian central nervous system ([@bib43]; [@bib44]). Deleting UNC-13L's C2A domain could also alter other aspects of synapse structure, such as SV trafficking, and coupling of SVs to Ca^2+^ entry at the release sites.

![Tonic release is reduced by disrupting C2A/RIM heterodimerization in low Ca^2+^.\
(**A**) Representative traces of mEPSCs and mIPSCs recorded at 0 mM Ca^2+^ from indicated genotypes. (**B, C**) Averaged frequency and amplitude of the mEPSCs and mIPSCs. (**D**) Representative traces of mEPSCs and mIPSCs recorded at 1 mM Ca^2+^ from the same genotypes in (**A**). (**E, F**) Quantification of the mEPSC and mIPSC frequency and amplitude from the genotypes in (**D**). Data are mean ± SEM (\#\#, p \< 0.01, \#\#\#, p \< 0.001, n.s., non-significant when compared to UNC-13L rescue; \*\*\*, p \< 0.001 when compared to wild-type; one-way ANOVA). The number of worms analyzed for each genotype is indicated in the bar graphs. (**G**) Quantification of the mEPSC and mIPSC frequencies at various Ca^2+^ levels (0, 0.05, 0.1, and 1 mM) from wild-type (black) and *unc-10*(*nu487* K77/79E) mutants (red). Data are mean ± SEM (\*\*\*, p \< 0.001, n.s., non-significant when compared to wild-type; student's t-test).](elife-40585-fig2){#fig2}
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###### Comparison of SV release.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                    Tonic release   Evoked EPSC   RRP          P~vr~                                                                                                      
  ----------------- --------------- ------------- ------------ ------------ ------------- ------------ ------------ ------------ ------------- ------------- ------------ ---------------
                    Frequency\      Amplitude\    Frequency\   Amplitude\   mIPSC\        Amplitude\   mIPSC\       Amplitude\   Amplitude\    Charge\       Charge\      
                    (Hz)            (-pA)         (Hz)         (-pA)        (Hz)          (pA)         (Hz)         (pA)         (-nA)         (-pC)         (-pC)        

                                                                                                                                                                          

  Wild-type         1.87 ± 0.16     23.2 ± 1.6    43.5 ± 4.3   23.9 ± 1.1   11 ± 1.1      25.9 ± 1.1   42.5 ± 4.1   22.5 ± 2.1   2.27 ± 02.    20.6 ± 2.1    221 ± 23.1   0.12 ± 0.01

  *unc-13(s69)*     0.05 ± 0.05     20.2 ± 3      2 ± 1        21.1 ± 2.1   0.05 ± 0.05   22.1 ± 4.1   1.1 ± 0.5    21.5 ± 3.2   0.02 ± 0.01   0.05 ± 0.01   25.5 ± 7.1   0

  UNC-13L           1.51 ± 0.45     19.3 ± 1.9    43.4 ± 3.7   23.9 ± 1.1   10.1 ± 0.9    22.3 ± 2.2   38.1 ± 3.5   22.4 ± 1.1   1.7 ± 0.14    15.4 ± 2.6    237 ± 25.4   0.06 ± 0.01

  UNC-14LΔC2A       0.64 ± 0.07     20.5 ± 1.4    20.2 ± 3     23.3 ± 2.2   5.4 ± 0.5 v   28.2 ± 1.9   34.4 ± 3.2   25.7 ± 1.8   1.08 ± 0.12   8.4 ± 1.6     248 ± 66.3   0.034 ± 0.006

  UNC-13L(K49E)     1.9 ± 0.48      19.4 ± 1.1    43.3 ± 4.3   19.3 ± 2.4   9.8 ± 1.2     23.4 ± 1.5   40.6 ± 5.1   23.7 ± 3.2   2.1 ± 0.27    17.3 ± 2.3    243 ± 38.3   0.07 ± 0.01

  unc-10(K77/79E)   0.57 ± 0.1      20.2 ± 1.8    45.4 ± 3.7   21.1 ± 1.2   3.5 ± 0.5     27.3 ± 1.8   39.7 ± 4.1   26.7 ± 1.1   1.18 ± 0.11   11.5 ± 1.5    245 ± 28.2   0.046 ± 0.006

  K49E;K77/79E      0.94 ± 0.18     23.1 ± 1.5    40.8 ± 4.4   22.2 ± 1.6   9.5 ± 1       26.3 ± 1.4   43.7 ± 6.3   26.5 ± 1.8   1.81 ± 0.15   18.1 ± 2.2    260 ± 40     0.07 ± 0.008

                                                                                                                                                                          
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

All data were collected from three independent experiments to ensure the observed phenotype are replicable.

We next asked whether C2A/C2A homodimerization or C2A/RIM heterodimerization accounts for the role of the C2A domain in tonic release. To investigate this, we first examined the mEPSCs and mIPSCs in the *unc-13* mutants rescued by UNC-13L carrying the K49E mutation, which blocks C2A/C2A homodimerization ([Figure 1B](#fig1){ref-type="fig"}). The mEPSC and mIPSC frequencies in the UNC-13L(K49E) rescue animals were comparable to those in the UNC-13L rescue animals in both 0 mM and 1 mM Ca^2+^ conditions ([Figure 2A--F](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}), indicating that homodimerization does not affect tonic ACh or GABA release. To determine the role of C2A/RIM heterodimerization, we used crispr to introduce a K77/79E double mutation in the UNC-10 ZF domain, *unc-10*(*nu487* K77/79E). Compared to wild-type animals, *unc-10*(*nu487* K77/79E) mutants display slightly uncoordinated behaviour (data not shown). Analysis of tonic release showed that the mEPSCs and mIPSCs were markedly reduced in *unc-10*(*nu487* K77/79E) mutants in 0 mM Ca^2+^, whereas both were unaltered in 1 mM Ca^2+^ ([Figure 2A--F](#fig2){ref-type="fig"}), suggesting that C2A/RIM heterodimerization is only required for tonic release in low Ca^2+^ when release probability is reduced. To confirm this, we measured mEPSCs and mIPSCs in two additional Ca^2+^ concentrations (0.05 mM and 0.1 mM). As shown in [Figure 2G](#fig2){ref-type="fig"}, increasing the Ca^2+^ concentration from 0 mM to 0.05 mM and 0.1 mM caused robust enhancement of the mEPSC and mIPSC frequencies in wild-type animals. In *unc-10*(*nu487* K77/79E) mutants, a significantly lower mIPSC frequency was observed in 0.05 mM Ca^2+^ but not in 0.1 mM Ca^2+^, whereas mEPSCs were unaltered in both 0.05 mM and 0.1 mM Ca^2+^ ([Figure 2G](#fig2){ref-type="fig"}). Our results therefore demonstrate that C2A/RIM heterodimerization promotes tonic release but that this effect is bypassed when release probability is increased by raising external Ca^2+^ concentrations.

A monomeric C2A domain is fully functional for tonic release {#s2-3}
------------------------------------------------------------

The decreased mEPSC frequency observed in the UNC-13LΔC2A rescue animals at 1 mM Ca^2+^ indicates that the C2A domain may have an additional function in regulating tonic release, particularly at high Ca^2+^. We therefore examined whether simultaneously blocking the homo- and heterodimerization of the C2A domain could account for this additional function. To do that, we made UNC-13L(K49E); *unc-10*(*nu487* K77/79E) double mutant by crossing the *unc-10*(*nu487* K77/79E) into the UNC-13L(K49E) rescue strain. In 0 mM Ca^2+^ recordings, the UNC-13L(K49E); *unc-10*(*nu487* K77/79E) double mutant mIPSC rate was significantly higher than that observed in *unc-10*(*nu487* K77/79E) single mutants, suggesting that blocking homodimer formation was sufficient to prevent the decreased tonic GABA release caused by the *unc-10*(*nu487* K77/79E) mutation ([Figure 2C](#fig2){ref-type="fig"}). By contrast, blocking homodimerization did not significantly improve mEPSC rates in 0 mM Ca^2+^ in *unc-10*(*nu487* K77/79E) mutants ([Figure 2B](#fig2){ref-type="fig"}). Thus, heterodimerization increases tonic GABA release by preventing homodimer formation, whereas heterodimerization promotes tonic ACh release by a distinct mechanism. In addition, the tonic ACh and GABA release were at wild-type level in the UNC-13L(K49E); *unc-10*(*nu487* K77/79E) double mutant in 1 mM Ca^2+^, similar to those in the UNC-13L(K49E) rescue and the *unc-10*(*nu487* K77/79E) mutant ([Figure 2E,F](#fig2){ref-type="fig"}). Taken together, these results demonstrate that blocking C2A homo- and heterodimerization does not decrease tonic ACh and GABA release. These results differ from those obtained in the UNC-13LΔC2A rescue animals, suggesting that the effect of deleting the C2A domain on the tonic release is not a result of a lack of homo- and heterodimerization.

Stimulus-evoked release is reduced when C2A/RIM heterodimerization is blocked {#s2-4}
-----------------------------------------------------------------------------

Next, we analysed the impact of C2A interactions on stimulus-evoked ACh release. Compared to UNC-13L, UNC-13LΔC2A exhibited a smaller evoked EPSC ([Figure 3A](#fig3){ref-type="fig"}, [Table 1](#table1){ref-type="table"}), consistent with previous findings ([@bib16]; [@bib42]). The evoked EPSCs were significantly smaller in *unc-10*(*nu487* K77/79E) mutants, exhibiting decreased amplitude and total charge transfer compared to wild-type animals ([Figure 3A--C](#fig3){ref-type="fig"}). The percentage decrease of the evoked charge transfer in the *unc-10*(*nu487* K77/79E) mutant (44%) was similar to that observed in the UNC-13LΔC2A rescue animals (46%), suggesting that C2A/RIM heterodimerization accounts for the role of the C2A domain in evoked release. Thus, our results revealed that C2A/RIM heterodimerization is required for evoked neurotransmitter release. It should be noted that the evoked EPSCs were recorded in 1 mM Ca^2+^ solution in which, however, the mEPSCs were unchanged ([Figure 2E](#fig2){ref-type="fig"}). These different observations on tonic and evoked neurotransmitter release may reflect differential release probabilities of the two release modes at various Ca^2+^ levels. Indeed, the mEPSCs and the stimulus-evoked EPSCs exhibit large differences in their Ca^2+^ dependence ([@bib39]).

![Effects of homodimerization and heterodimerization on evoked neurotransmitter release.\
Electronic stimulus and hypertonic sucrose-evoked EPSCs were recorded from the body wall muscle of adult animals in 1 mM Ca^2+^. (**A**) Example traces of the evoked EPSCs from indicated genotypes. (**B--D**) Quantification of the amplitude, charge transfer and 20--80% risetime of the evoked EPSCs in (**A**). Example traces and averaged charge transfer of the sucrose-evoked EPSCs from the same genotypes in (**A**) are shown in (**E**) and (**F**). (**G**) Quantification of the probability of SV release (P~vr~). Data are mean ± SEM (\*, p \< 0.05, \*\*, p \< 0.01, \*\*\*, p \< 0.001 when compared to wild-type; \#, p \< 0.05, n.s., non-significant when compared to UNC-13L rescue; one-way ANOVA).](elife-40585-fig3){#fig3}

Next, we asked whether C2A homodimers regulate evoked responses. The evoked EPSCs mediated by UNC-13L(K49E) were indistinguishable from those rescued by wild-type UNC-13L, indicating that C2A homodimers are not required for evoked responses ([Figure 3A--C](#fig3){ref-type="fig"}). To determine whether homodimers inhibited evoked ACh release, we analyzed UNC-13L(K49E); *unc-10(nu487* K77/79E) double mutants. We found that preventing C2A/C2A homodimerization in the *unc-10(nu487* K77/79E) mutant fully restored the evoked EPSC to a wild-type level ([Figure 3A--C](#fig3){ref-type="fig"}). These results suggest that the reduced evoked EPSC caused by blocking C2A/RIM heterodimerization is mediated by increased formation of C2A homodimers. These results are consistent with prior analysis of mouse synapses, which suggest that Munc13-1 homodimers inhibit SV release ([@bib10]). These results also demonstrate that the monomeric C2A domain is sufficient to support evoked release, consistent with the observation of tonic release ([Figure 2](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). Thus, the RIM ZF domain appears to function only as a switch that releases the C2A domain from the inhibitory homomeric complex.

The C2A domain is not required for SV priming {#s2-5}
---------------------------------------------

A decrease in evoked EPSCs may arise from a priming defect or a change in release probability. We therefore examined whether SV priming is regulated by the C2A domain and its two different states (homodimer and heterodimer). SV priming was measured by the pulsed application of hypertonic sucrose solution (1M, 2 s) onto the ventral nerve cord, and the size of the RRP was calculated by integrating the sucrose-evoked current. The current was almost eliminated in the *unc-13* null mutants, and was fully restored by expressing a wild-type UNC-13L transgene in all neurons ([Figure 3E](#fig3){ref-type="fig"}). Strikingly, UNC-13L lacking the C2A domain could still restore the sucrose-evoked current to a wild-type level ([Figure 3E,F](#fig3){ref-type="fig"}, [Table 1](#table1){ref-type="table"}), indicating that the C2A domain is not required for SV priming. These results differ from those reported in mouse hippocampal neurons, in which the RRP was largely reduced when the Munc13-1 C2A domain was removed ([@bib8]). Despite these differences, our results, together with those obtained in chromaffin cells in which Munc13-1 lacking the C2A domain enhances secretion to as high a level as does Munc13-1 ([@bib5]), support the notion that truncated UNC-13 lacking the C2A domain is still able to prime SVs.

The C2A deletion had no effect on SV priming, suggesting that C2A/C2A homodimerization and C2A/RIM heterodimerization are also not required for priming. Nevertheless, we assessed the RRP size in the UNC-13L(K49E) rescue animals and the *unc-10*(K77/79E) mutant by puffing hypertonic sucrose (1M, 2 s). Our data showed that the sucrose-evoked currents in these animals were comparable to those observed in UNC-13L rescue and wild-type animals ([Figure 3E,F](#fig3){ref-type="fig"}), demonstrating that homodimerization or heterodimerization is not playing a role in SV priming. The unchanged SV priming in the *unc-10*(K77/79E) mutant was also confirmed by puffing a lower concentration of sucrose (0.5M, 5 s; data not shown). Consequently, the probability of synaptic vesicle release (P~vr~) calculated by the ratio of the charge transfer of the evoked EPSCs to the charge transfer of the sucrose-evoked currents was significantly reduced in the ΔC2A rescue and the *unc-10*(K77/79E) mutant ([Figure 3G](#fig3){ref-type="fig"}). It should be noted that recording of the sucrose-evoked current requires a tight gigaohm seal between the recording pipette and the cell, as a loose seal often leads to an unreal current. We therefore analyzed the leak currents for each sucrose recording. Our data showed that all recordings were controlled well with acceptable leak currents ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Together, our results demonstrate that the UNC-13L C2A domain regulates release probability by interacting with the UNC-10/RIM, rather than by regulating SV priming.

The decreased release probability in the UNC-13LΔC2A rescue and the *unc-10*(K77/79E) mutant could arise from a change in the expression level of UNC-13, or a change in sub-localization of the UNC-13 proteins at the nerve terminals. We next analyzed the UNC-13 protein levels from different transgenic rescue lines. A fluorescence protein (mApple) was fused to the C terminus of the various UNC-13L constructs (WT, K49E, and ΔC2A), and expressed in *unc-13* null mutants. Our prior study showed that c-terminal mCherry tags do not interfere with UNC-13's function in promoting SV exocytosis ([@bib16]). All mApple-tagged UNC-13L constructs rescued the SV release in the *unc-13* mutants, and the phenotypes were similar to those rescued by corresponding untagged UNC13L constructs ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). By quantifying the mApple fluorescence intensity from different rescue lines, we showed that there were no significant differences ([Figure 4A,B](#fig4){ref-type="fig"}), indicating that the UNC-13 proteins were expressed at similar levels in these lines. These results suggest that the decreased tonic and evoked release in UNC-13LΔC2A rescued animals are unlikely to result from reduced UNC-13L abundance. Prior studies have shown that the C2A domain is crucial for synaptic localization of UNC-13 ([@bib27]). Therefore, it is likely that the decrease in release probability in the UNC-13LΔC2A rescue animals was caused by mis-localization of UNC-13 at the active zone.

![Expression of UNC-13 transgenic constructs and effects of disrupting UNC-13L/RIM heterodimerization on sub-localization of UNC-13L.\
(**A**) Presynaptic distribution of UNC-13 at the dorsal nerve cord in *unc-13* animals rescued by the indicated transgenic constructs. Scale bar, 5 μm. (**B**) Quantification of the mApple fluorescence intensity from the transgenic rescue lines in (**A**). (**C**) Representative confocal Z-stack images for UNC-13L and ELKS-1 in wild-type background. Scale bar, 5 μm. (**D**) Line scans along the dorsal nerve cord. (**E**) Representative confocal Z-stack images for UNC-13L and ELKS-1 in *unc-10*(K77/79E) mutants. (**F**) Line scans along the dorsal nerve cord. Data are mean ± SEM (n.s., non-significant; one-way ANOVA). The number of worms analyzed for each genotype is indicated in the bar graphs.](elife-40585-fig4){#fig4}

We next asked if the decreased release probability in the *unc-10*(K77/79E) mutant was caused by a change in the sub-localization of UNC-13L. To determine this, we compared colocalization of UNC-13L and an active zone marker (ELKS-1) in wild-type controls and in *unc-10*(K77/79E) mutants. UNC-13L and ELKS-1 were strongly colocalized in wild-type ([Figure 4C,D](#fig4){ref-type="fig"}), and this colocalization was not obviously altered in *unc-10*(K77/79E) mutants ([Figure 4E,F](#fig4){ref-type="fig"}). These results suggest that disrupting UNC-13L binding to RIM does not prevent synaptic localization of UNC-13L.

Disrupting heterodimerization does not affect synaptic depression and recovery {#s2-6}
------------------------------------------------------------------------------

Because of the reduced P~vr~ in the *unc-10*(K77/79E) mutant, we asked whether the synaptic depression and recovery would be altered by disruption of C2A/RIM heterodimerization. An integrated line expressing ChIEF, a variant of channelrhodopsin-2 (ChR2) in the cholinergic motor neurons was used to record the EPSCs evoked by a train or a paired light stimulus ([@bib22]; [@bib37]). Both the control animals and the *unc-10*(K77/79E) mutants exhibited synaptic depression following a 1 Hz or 5 Hz train stimulus ([Figure 5A,C](#fig5){ref-type="fig"}). The depression rate was described by normalizing the amplitudes of all the EPSCs (EPSC~i~) to the amplitude of the first EPSC (EPSC~1~). The *unc-10*(K77/79E) mutants displayed a similar depression rate to that of the control animals ([Figure 5B,D](#fig5){ref-type="fig"}), indicating that RIM binding to the C2A domain is not required for synaptic depression. To assess synaptic recovery, we applied a paired stimulus by changing the intervals between the two stimuli (50 ms, 100 ms, 200 ms, 500 ms, 1 s, 5 s) ([Figure 5E](#fig5){ref-type="fig"}). The recovery rate was quantified by the ratio of the second EPSC amplitude (EPSC~2~) to the first EPSC amplitude (EPSC~1~). As shown in [Figure 5F](#fig5){ref-type="fig"}, no difference in the recovery rate was observed between the control animals and the *unc-10*(K77/79E) mutants. This indicates that disrupting C2A/RIM binding does not affect refilling of the SVs at synapses.

![Synaptic depression and recovery are unaltered by disrupting C2A/RIM heterodimerization.\
Synaptic depression and recovery were investigated by applying a train (1 Hz or 5 Hz) or a paired light stimulus onto the ventral nerve cord of the adult worms with expression of ChIEF in cholinergic motor neurons. (**A, C**) Example traces of 1 Hz and 5 Hz light train stimulus-evoked EPSCs (black, wild-type; red, *unc-10*(K77/79E) mutants). (**B, D**) Quantification of synaptic depression by normalizing the EPSC amplitude (EPSC~i~) to the first EPSC amplitude (EPSC~1~). (**E**) Evoked EPSCs triggered by a paired light stimulus with various intervals ranging from 0.05 s to 5 s. (**D**) Synaptic recovery calculated by the ratio of EPSC~2~ to EPSC~1~ (wild-type, 50 ms = 7, 100 ms = 8, 200 ms = 11, 500 ms n = 7, 1 s n = 18, 5 s n = 8; *unc-10*(*nu487* K77/79E) mutant, 50 ms = 5, 100 ms = 7, 200 ms = 11, 500 ms n = 10, 1 s n = 14, 5 s n = 7). Data are mean ± SEM (n.s., non-significant when compared to wild-type; student's t-test).](elife-40585-fig5){#fig5}

Discussion {#s3}
==========

In this study, we analyzed the functional importance of the C2A domain of UNC-13L, a Munc13-1 homolog in *C. elegans*, for SV priming and release probability. Prior studies in mouse and *C. elegans* have reported contradictory results regarding the role of the C2A domain in priming ([@bib5]; [@bib42]; [@bib8]). This motivated us to investigate the function of this domain, with a particular focus on its two binding modes, in SV priming and post-priming Ca^2+^-triggered exocytosis. Below we discuss our findings.

UNC-13L primes SVs independently of the C2A domain {#s3-1}
--------------------------------------------------

The fact that the UNC-13/Munc13 is required for SV priming has been reported in both invertebrates and vertebrates ([@bib1]; [@bib2]; [@bib33]). Sucrose-evoked responses are almost eliminated in neurons lacking UNC-13 or Munc13. Thus far, however, it is still unclear how the priming activity of UNC-13/Munc13 is achieved and regulated. It is believed that the MUN domain plays an essential role in SV priming. Removing the C2A domain from Munc13-1 leads to a marked decrease in the RRP of SVs in cultured hippocampal neurons, suggesting a role for C2A in priming ([@bib8]). However, we found that *unc-13* mutants lacking a C2A domain (UNC-13LΔC2A rescued animals) exhibit a normal RRP, arguing that the C2A domain is not required for priming ([Figure 3E](#fig3){ref-type="fig"}). Zhou et al. showed that an isolated *unc-13* mutant (*n2609*) with a point mutation in the C2A domain of UNC-13L exhibits a similar reduction in evoked EPSCs to UNC-13LΔC2A, whereas docked SV numbers are normal in the *unc-13(n2609)* mutant. This suggests that the C2A domain is not required for docking ([@bib42]), consistent with our observations in relation to priming. It should be noted that all the UNC-13 transgenes in this study are extrachromosomal arrays, and that the UNC-13 proteins are overexpressed in these transgenic animals. The overexpression of UNC-13 may cause differential effects with wild-type expression of this protein. Despite this, our findings (e.g., ΔC2A) are similar to the results of Zhou et al., which were obtained from *unc-13* mutants rescued by a single copy of UNC-13.

Our results imply that UNC-13L regulates SV priming via a different mechanism, and that this mechanism is independent of the C2A domain. Prior studies have shown that a point mutation in the C1 domain of Munc13-1 accelerates hypertonicity-induced SV release without changing the size of the RRP ([@bib4]). Transgenic *C. elegans* rescued by a truncated UNC-13L lacking its C1 or C2B domain also exhibit a normal RRP ([@bib28]). Expression of a mutated Munc13-1 (P827L, located in the linker domain between C2B and MUN) leads to a significant increase in release probability without causing an increase in the size of the RRP ([@bib21]). These observations appear to support the notion that the regulatory domains in UNC-13L (e.g. C2A, C1 and C2B) alter release probability but are not required for SV priming. Thus, our results, together with the findings from other studies in *C. elegans* and mouse, suggest that UNC-13 has multiple regulatory effects on synaptic strength and plasticity, which are achieved by differential control of release probability by its various functional domains.

State of the C2A domain and release probability {#s3-2}
-----------------------------------------------

The reduced evoked EPSCs and unchanged RRP in the UNC-13LΔC2A rescue animals led to a significant decrease in release probability (P~vr~), consistent with previous studies ([@bib8]). Similar to these observations, the *unc-10*(K77/79E) mutant also exhibits an impairment in evoked EPSCs but a normal RRP, thereby leading to a decreased P~vr~ ([Figure 3](#fig3){ref-type="fig"}). These results demonstrate that deleting the C2A domain or blocking C2A/RIM heterodimerization decreases release probability. It should be noted that, release probability remains unchanged in the hippocampal neurons when C2A/RIM heterodimerization is disrupted, because of a similar decrease in the evoked EPSCs and the RRP ([@bib8]), different from our findings in this study.

The function of the C2A domain in regulating the release probability appears to be determined by its state. It has been proposed that the Munc13 C2A domain has three binding states, homodimer, heterodimer, and monomer, and that these three forms may co-exist in synaptic terminals. The decrease in evoked EPSC and release probability in the *unc-10*(*nu487* K77/79E) mutant was blocked by disrupting C2A/C2A homodimerization ([Figure 3](#fig3){ref-type="fig"}). This indicates that the synaptic transmission defect caused by disrupting C2A/RIM heterodimerization occurs because of an increase in C2A/C2A homodimerization, which is proposed to comprise an autoinhibitory state. Again, this is post-priming regulation, as SV priming is normal in both the UNC-13L(K49E) rescue and UNC-13L(K49E); *unc-10*(*nu487* K77/79E) animals ([Figure 3E](#fig3){ref-type="fig"}). Although our findings are similar to the observations reported in cultured hippocampal neurons in which the reduced evoked EPSCs caused by the disruption of heterodimerization were partially recovered when homodimerization and heterodimerization were disrupted simultaneously ([@bib8]), we found that UNC-13L with a monomeric C2A domain is fully functional for both the priming and post-priming Ca^2+^-triggered tonic and evoked release. Thus, our results support the notion that homodimerization of the C2A domain inhibits SV release, and that RIM releases the C2A domain from the autoinhibitory homodimeric complex by competitively binding the C2A domain to form a heterodimer, thereby allowing the C2A domain to become fusion-competent. The heterodimer itself, however, does not produce an additional effect on synaptic transmission.

Distinct priming mechanisms between worm and mouse? {#s3-3}
---------------------------------------------------

RIM binding to Munc13-1 is a key determinant in SV priming in the mouse central nervous system. In fact, deleting Munc13-1 C2A or disrupting C2A/RIM heterodimerization leads to a similar reduction in the size of the RRP to that observed in RIM knockout neurons ([@bib10]; [@bib8]). Whereas SV priming in worm does not rely on the UNC-13 C2A and the heterodimerization of UNC-13/RIM, although this interaction is highly conserved between worm and mouse. This raises a question of whether the UNC-10/RIM is required for priming in worm. Electron microscopy results have revealed that the number of docked SVs is slightly decreased in the *unc-10* mutant ([@bib20]; [@bib38]; [@bib12]), which cannot account for the far more dramatic SV fusion defect, suggesting a post-docking role of RIM in the active zone. Consistent with these relatively minor docking defects, we found that the size of the RRP in *unc-10* mutants (assessed by sucrose evoked currents) is comparable to that in the wild-type animals (data not shown), demonstrating that UNC-10/RIM is not required for SV priming. These results suggest that UNC-10/RIM primarily regulates SV fusion by increasing release probability and not by promoting SV priming. UNC-10/RIM increases release probability via its ability to bind UNC-13 but also through its requirement for recruiting CaV2 calcium channels to presynaptic terminals ([@bib14]; [@bib19]; [@bib29]).

Why does RIM play different roles at worm and mouse synapses? SV priming is thought to consist of two sequential steps, termed molecular and positional priming ([@bib30]). Molecular priming is proposed to account for a slow component of release, which consists of fusion of SVs that are docked far from calcium channels driving release. Positional priming is proposed to mediate a faster form of release, which comprises fusion of SVs that are docked very close to calcium channels. One possibility is that worms rely less on positional priming, which presumably requires UNC-13/RIM interaction, and instead rely more on molecular priming. In this scenario, worm *unc-10* RIM mutants would have decreased release probability but relatively normal RRP size. By contrast, mice may require positional priming to maintain the RRP, and thus RIM mutants would have significant priming defects.

Additional functions of the C2A domain {#s3-4}
--------------------------------------

Despite the above findings, the actual mechanism whereby the UNC-13L with a monomeric C2A regulates SV release remains unclear. Based on the normal synaptic transmission in the UNC-13L(K49E); *unc-10*(*nu487* K77/79E) double mutants, RIM binding to the UNC-13L C2A domain only appears to be playing a switch role. The C2A domain must therefore have additional functions for regulation of SV release. This is confirmed by our observations in relation to tonic release, which has been proposed to have a different regulatory mechanism from evoked release ([@bib32]; [@bib27]). The mEPSC frequency was reduced by 50% in the UNC-13LΔC2A rescue animals at both 0 mM and 1 mM Ca^2+^, similar to the evoked release findings ([Figure 2](#fig2){ref-type="fig"}), revealing an important role of the C2A domain for tonic release at cholinergic synapses. However, this role cannot be explained by the state of the C2A domain (homodimer, heterodimer, or monomer), as the mEPSC frequencies were normal in the UNC-13L(K49E) rescue, *unc-10*(*nu487* K77/79E) mutant, and UNC-13L(K49E); *unc-10*(*nu487* K77/79E) double mutants in 1 mM Ca^2+^. We only observed a change in the Ca^2+^ sensitivity in very low Ca^2+^ at GABAergic synapses, and this phenotype disappeared when the Ca^2+^ levels were increased ([Figure 2G](#fig2){ref-type="fig"}). Our observations at cholinergic synapses therefore demonstrate that, although the C2A/C2A homodimer inhibits evoked release, it does not affect tonic release. There must still be an unknown mechanism by which the monomeric C2A domain regulates post-priming SV exocytosis.

Materials and methods {#s4}
=====================

Strains {#s4-1}
-------

Strain maintenance and genetic manipulation were performed as previously described ([@bib6]). Animals were cultivated at room temperature on nematode growth medium (NGM) agar plates seeded with OP50 bacteria. On the day before experiments L4 larval stage animals were transferred to fresh plates seeded with OP50 bacteria for all the electrophysiological recordings. The following strains were used:

Wild-type, N2 bristol

KP6901 *unc-13(s69)* I

KP7503 *nu487 unc-10*(*nu487* K77/79E), X

KP6893 nuEx1515 \[P*snb-1*::UNC-13L\];*unc-13(s69)*

ZTH6 *unc-13(s69);*hztEx106 *\[Psnb-1::UNC-13LΔC2A\]*

ZTH454 *unc-13(s69);*hztEx91 *\[Psnb-1::UNC-13L(K49E)\]*

ZTH7 *unc-10(nu487 K77/79E);*hztEx91 \[*Psnb-1::UNC-13L(K49E); unc-13(s69)*\]

ZX460 zxIs6 \[*Punc-17::ChR2(H134R)::YFP +lin-15(+)*\] V

ZTH71 *unc-10*(*nu487* K77/79E);zxIs6

ZTH605 *unc-13(s69);*hztEx76 *\[Psnb-1::UNC-13L::mApple\]*

ZTH606 *unc-13(s69);*hztEx77 *\[Psnb-1::UNC-13LΔC2A::mApple\]*

ZTH607 *unc-13(s69);*hztEx78 *\[Psnb-1::UNC-13L(K49E)::mApple\]*

JSD0025 tauIs12 (9x) *\[Punc-129::ELKS-1::Cerulean::Cerulean LG\]*

EG5793 *oxSi91\[Punc-17::ChIEF::mCherry::unc-54UTR; unc-119*(+)\] *II*

ZTH608 *unc-10*(*nu487* K77/79E);*oxSi91, MosSCI*

'Ex' in the strain name indicates that the rescue experiments use extrachromosomal array.

Constructs, transgenes and germline transformation {#s4-2}
--------------------------------------------------

A 5.451 kb cDNA corresponding to UNC-13L was amplified by PCR from the N2 cDNA library and inserted into MCSII of the JB6 vector between the KpnI and NotI sites. The *snb-1* promoter (3 kb) was inserted into MCSI between the SphI and BamHI sites. The C2A domain deletion removed the first 150 amino acids. The 5' primer (GCTGCAGACTGTAGAATCAACAACTGT) and 3' primer (ACAGTTGTTGATTCTACAGTCTGCAGC) were used to create the P*snb-1*::UNC-13L(K49E) construct.

Transgenic strains were isolated by microinjection of various plasmids using either Pmyo-2::NLS-GFP (KP\#1106) or Pmyo-2::NLS-mCherry (KP\#1480) as the co-injection marker. Integrated transgenes were obtained by UV irradiation of strains carrying extrachromosomal arrays. All integrated transgenes were outcrossed at least seven times.

Electrophysiology {#s4-3}
-----------------

Electrophysiology was conducted on dissected *C. elegans* as previously described ([@bib15]). Worms were superfused in an extracellular solution containing 127 mM NaCl, 5 mM KCl, 26 mM NaHCO~3~, 1.25 mM NaH~2~PO~4~, 20 mM glucose, 1 mM CaCl~2~, and 4 mM MgCl~2~, bubbled with 5% CO~2~, 95% O~2~ at 22°C. The 1 mM CaCl~2~ was replaced by 1 mM MgCl~2~ to record mEPSCs and mIPSCs in 0 mM of Ca^2+^. Whole-cell recordings were carried out at −60 mV for all EPSCs, including mEPSCs, evoked EPSCs, and sucrose-evoked responses. The holding potential was switched to 0 mV to record mIPSCs. The internal solution contained 105 mM CH~3~O~3~SCs, 10 mM CsCl, 15 mM CsF, 4 mM MgCl~2~, 5 mM EGTA, 0.25 mM CaCl~2~, 10 mM HEPES, and 4 mM Na~2~ATP, adjusted to pH 7.2 using CsOH. Stimulus-evoked EPSCs were stimulated by placing a borosilicate pipette (5--10 μm) near the ventral nerve cord (one muscle distance from the recording pipette) and applying a 0.4 ms, 85 μA square pulse using a stimulus current generator (WPI). A pulsed application of sucrose (1M, 2 s) was applied onto the ventral nerve cord using a Picospritzer III (Parker). The glass pipette containing sucrose was placed at the end of the patched muscle (around half muscle distance from the recording pipette).

Fluorescence imaging {#s4-4}
--------------------

Animals were immobilized on 2% agarose pads with 30 mM levamisole. Fluorescence imaging was performed on a spinning-disk confocal system (3i Yokogawa W1 SDC) controlled by Slidebook 6.0 software. Animals were imaged with an Olympus 100 × 1.4 NA Plan-Apochromat objective. Z series of optical sections were acquired at 0.11 μm steps. Images were deconvolved with Huygens Professional version 16.10 (Scientific Volume Imaging, The Netherlands) and then processed to yield maximum intensity projections using ImageJ 1.51 n (Wayne Rasband, National Institutes of Health).

Isothermal titration calorimetry (ITC) {#s4-5}
--------------------------------------

ITC experiments were performed using a Nano ITC (TA Instruments). ITC titrations were performed in degassed 20 mM HEPES pH 7.5, 150 mM NaCl at 25°C. After baseline subtraction, the area under each peak was integrated and data were fit to a one site independent binding model usingNanoAnalyze software (TA Instruments) to determine the binding affinity (K), enthalpy (dH) and stoichiometry (n); binding was not observed for *unc-10* 62--121 K77/79E.

*Protein expression and purification (for ITC experiments): C. elegans* UNC-13 long isoform residues 1--258 bearing the K49E mutation (which abolishes homodimer formation), *C. elegans* UNC-10 residues 62--121 WT or *C. elegans* UNC-10 K77/79E were expressed from pGEX6p1 as a GST fusion in Rosetta2 (DE3) cells. Cells were grown at 37°C in 6L 2xyt with carbenicillin (100 µg/mL), chloramphenicol (35 µg/mL) and ZnSO~4~ (200 µM, Unc-10 constructs only), to O.D.600 \~ 0.5, then allowed to cool down to 18°C for an hour before induction with 1 mM IPTG overnight at 18°C. The cells were harvested the next day and lysed in 20 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM PMSF, 1% Triton X-100, 1 mM DTT, 200 µM ZnSO~4~ (UNC-10 constructs only); the cells were sonicated 3 × 40 s using a midi tip, and lysates clarified 45 mins @ 40,000 rpm, 4°C in a Sorvall Type 45 Ti rotor. Clarified lysates were bound to 1.5 mL (bed volume) glutathione sepharose beads tumbling overnight at 4°C. The next day, the beads were washed extensively, and HRV3C protease added for on-beads cleavage overnight at 4°C. The eluted soluble constructs were concentrated and subjected to gel filtration on a Superdex 75 10/300 against 20 mM HEPES pH 7.5 150 mM NaCl at 4°C. Single peaks corresponding to the monomeric proteins were concentrated to 21 µM (UNC-13L residues 1--258), to 140 µM (UNC-10 62--121 WT) and to 116 µM (UNC-10 62--121 K77/79E mutant), and used in the ITC experiment.

Data acquisition and statistical analysis {#s4-6}
-----------------------------------------

All recordings were obtained using a HEKA EPC10 double amplifier (HEKA Elektronik) filtered at 2 kHz, and analyzed by built-in programs in Igor seven software (WaveMetrics). Each set of data represents the mean ± SEM of an indicated number (n) of animals. Statistical significance was determined using student's-t test or one-way ANOVA followed by Dunnett's test to control for multiple comparisons.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Heterodimerization of UNC-13/RIM regulates synaptic vesicle release probability but not priming\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Josep Rizo as the Reviewing Editor, and the evaluation has been overseen by Randy Schekman as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Nils Brose (Reviewer \#2) and Janet Richmond (reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Liu et al. present a very interesting story on a very important aspect of synapse biology: the mechanism by which the interplay between UNC-13 and UNC-10 determines presynaptic function. UNC-13/Munc13 proteins are essential regulators of synaptic vesicle priming. Their loss causes a complete arrest of transmitter release, and their regulation by protein-interactors or second messengers determines several key aspects of synapse function, most notably short-term synaptic plasticity. In this regard the focus on the UNC-13/UNC-10 interaction is important and of very substantial interest because the accounts in the literature are confusing, with evidence for (and against) roles in synapse targeting and sub-synaptic localization of UNC-13/Munc13 and in the regulation of UNC-13/Munc13 dimerization and UNC-13/Munc13 activity. Liu et al. show that the UNC-13L C2A domain homodimerizes and also heterodimerizes with UNC-10, in correlation with previous results obtained with the mammalian proteins. Their data suggest that the UNC-13L C2A domain and its interaction with UNC-10 are important to increase the release probability but do not control priming. The latter result contrasts with data described in Camacho et al., 2017. The reasons for this apparent discrepancy are not clear, but the reviewers believe that the present results will be of substantial interest to the field of synapse biology and, overall, are supportive of the manuscript. However, they also have a number of concerns that are summarized below.

Essential revisions:

1\) Earlier studies showed that a truncation of mammalian Munc13-1 that abolishes RIM1 binding leads to a priming defect that can be (partially) overcome by prolonged strong overexpression of the truncated Munc13-1 variant (Betz et al., -- 2001 --). This indicated that the Munc13/RIM interaction might play a role in the synaptic trafficking and sub-synaptic positioning and anchoring of Munc13s. This notion is supported by the fact that Munc13-1 and ubMunc13-2 levels are massively reduced in RIM1 KO mice. Subsequent analyses in RIM1 KOs showed that synaptic targeting and active zone anchoring of Munc13-1 (and of the other RIM-binding Munc13, ubMunc13-2) are perturbed in the absence of RIM1 (Andrews-Zwilling et al. -- 2006 -- J. Biol. Chem. 281, 19720). In a parallel study, it was shown that perturbation of the Munc13-RIM interaction by infusion of the isolated RIM2 ZnF domain strongly inhibits transmitter release from the calyx of Held while a Munc13-binding-deficient ZnF domain variant does not (Dulubova et al., -- 2005 --), which corroborates the earlier/parallel work cited above. Since the first study on the functional effects of the RIM-Munc13 interaction on Munc13-dimerization (Deng et al., -- 2011 --), the whole field focused almost exclusively on this issue, without addressing the effects of perturbing RIM/Munc13 or UNC-13/UNC-10 interactions on Munc13/UNC-13 localization (beyond the analysis of the mere presence or absence of Munc13/UNC-13 at synapses). This is unfortunate because we know that the levels of Munc13/UNC-13 at synapses and its sub-synaptic positioning affect key synapse features. In addition, previous studies in *C. elegans* showed altered distributions of docked vesicles away from the active zone in the presence of UNC-13 constructs lacking the C2A domain as well as UNC-10 mutants, and this positional effect likely accounts for the reduced release probability observed in the present study. Liu et al. did not analyze sub-cellular localization and did not present expression data to determine the levels of the protein constructs reintroduced in the nerve cord. This is problematic given that all of the UNC-13 constructs are extrachromasomal arrays and thus could be highly or differentially expressed. Furthermore, the present study would have benefited from using CRISPR or some other form of homologous recombination throughout, as was done for their UNC-10 (K77/79E) construct so that expression level effects do not confound the interpretation of the results. Of particular concern is the possibility that overexpression of UNC-13 K49E in the rescue of release in the UNC-10 (K77/79E) background may not be physiologically relevant.

For these reasons, the present study and its interpretation would profit tremendously from a comparative analysis of the expression levels and sub-cellular localization of the different UNC-13 variants at synapses (as well as of UNC-13 levels and positioning in the presence of the different UNC-10 variants). If analyzing sub-synaptic UNC-13 localization cannot be performed within a reasonable timeframe for this communication, the authors should at least quantify the synaptic UNC-13 levels. The authors should also discuss these various issues and tone down their conclusions accordingly (including the definitive nature of the title).

2\) Crucial differences observed between the results described by Liu et al. and by Camacho et al., 2017 correspond to the measurements of the readily-releasable pool (RRP) of vesicles by treatment with hypertonic sucrose. It is unclear whether these are indeed real differences between the mammalian and worm systems, or the different results arise from differences in experimental protocols. For instance, the authors use 1 M sucrose instead of 500 mM sucrose, which is more common and was used by Camacho et al. It is also plausible that differences might arise from the method of application of sucrose. The authors should perform experiments with 500 mM sucrose to examine whether their results stand at this lower concentration, provide more experimental details on these experiments and discuss how experimental details might influence the results obtained. Raw traces for both concentrations should be provided and, when collecting the 500 mOsm data, the leak current for each trace used in the analysis should be noted.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"Heterodimerization of UNC-13/RIM regulates synaptic vesicle release probability but not priming in *C. elegans*\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Randy Schekman as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Nils Brose (Reviewer \#2); Janet E Richmond (Reviewer \#3).

The reviewers have discussed the reviews with one another and with the Reviewing Editor. They found most revisions satisfactory, but there are still some concerns that are summarized below to help you prepare a revised submission.

1\) The authors produced new extrachromasomal lines for the UNC-13 constructs tagged with C-terminal Apple, which allowed them to measure comparable expression levels, but these were not the arrays used to do the functional electrophysiological analysis in the paper. It is the case that arrays can vary in expression levels from one injection to the next. The authors only provide assurances that the behavior was rescued but did not show the data or the extent of the rescue. More concerning, they did not repeat the electrophysiological analyses on these strains. Without this, how can we be certain that these are similar to the original array-expressing strains and that the same results would be found.

2\) As for the hyperosmotic traces, only those for the unc-10(k77/79E) were reexamined in 0.5M sucrose and the requested leak currents for the two data sets (i.e. 0.5 and 1M) were not provided. The concern is that at 1M sucrose, if there were substantial leak, the large inward currents observed would arise not from sucrose-induced release but poor seals. This problem has arisen in the past in analyses of fly embryos in which large inward currents were observed in mutants that were subsequently shown to have no primed vesicles; the reason was leaky recordings. If the authors could have produced these data for the *unc-13* null and the UNC-13 rescuing arrays tagged with Apple, this would have greatly improved confidence in the conclusions of the paper. The leak currents should be provided and the data should be interpreted considering these issues.

3\) In the decision letter a critical discussion of the use of extrachromosomal-array-based expression was provided. Clearly, overexpression via this approach could mask effects that would become detectable with WT-like expression levels. This issue should be discussed briefly as a possible caveat.

10.7554/eLife.40585.013

Author response

> Essential revisions:
>
> 1\) Earlier studies showed that a truncation of mammalian Munc13-1 that abolishes RIM1 binding leads to a priming defect that can be (partially) overcome by prolonged strong overexpression of the truncated Munc13-1 variant (Betz et al., 2001).\[...\] Furthermore, the present study would have benefited from using CRISPR or some other form of homologous recombination throughout, as was done for their UNC-10 (K77/79E) construct so that expression level effects do not confound the interpretation of the results. Of particular concern is the possibility that overexpression of UNC-13 K49E in the rescue of release in the UNC-10(K77/79E) background may not be physiologically relevant.
>
> For these reasons, the present study and its interpretation would profit tremendously from a comparative analysis of the expression levels and sub-cellular localization of the different UNC-13 variants at synapses (as well as of UNC-13 levels and positioning in the presence of the different UNC-10 variants). If analyzing sub-synaptic UNC-13 localization cannot be performed within a reasonable timeframe for this communication, the authors should at least quantify the synaptic UNC-13 levels. The authors should also discuss these various issues and tone down their conclusions accordingly (including the definitive nature of the title).

We agree that the synaptic levels and localization of Munc13/UNC-13 proteins at the nerve terminals are essential for SV exocytosis. The use of extrachromosomal arrays in this study raised the question of whether the UNC-13 protein levels from distinct transgenic lines (UNC-13L, UNC-13LK49E, and UNC-13LDC2A rescues) are similar or not.

To determine this, we made all the rescue constructs with a fluorescence protein tag (mApple). Re-introducing these constructs into the *unc-13* null mutants rescued the locomotion defects (data not shown). Indeed, the UNC-13 with a C-terminal tag is fully functional in mediating SV exocytosis (Hu et al., 2013). By analyzing the fluorescence intensity of mApple, we showed that the average proteins levels of UNC-13L, UNC13LK49E, and UNC-13LDC2A are not significantly different (Figure 4A, B). These results exclude the possibility that the decreased SV release in the UNC-13LDC2A rescue is due to a change in the protein level, and that disrupting the C2A/C2A homodimerization has no effect on protein level. It should be noted that we didn't compare release in these new mApple transgenic strains, as prior studies have shown that a fluorescence tag does not affect UNC-13 protein's function (Madison et al., 2005; Hu et al., 2013).

To examine whether the sub-localization of UNC-13L is altered when heterodimerization with RIM is disrupted, we analyzed UNC-13L co-localization with ELKS1, another active zone protein. In wild-type background, UNC-13L (tagged with mCherry) and ELKS^-1^ (tagged with Cerulean) exhibit an obvious colocalization (Figure 4C, D). This colocalization was still observed in *unc-10*(K77/79E) mutants (Figure 4E, F). These results suggest that disrupting the UNC-13L/RIM interaction does not dramatically alter UNC-13L synaptic localization and that UNC-13L likely has other binding partners that promote its active zone localization.

All the above results have been incorporated into the figures and text.

"The decreased release probability in the UNC-13LDC2A rescue and the *unc-10*(K77/79E) mutant could arise from a change of the expression level of UNC-13, or a change of the sublocalization of the UNC-13 proteins at the nerve terminals. \[...\] These results suggest that disrupting UNC-13L binding to RIM does not prevent synaptic localization of UNC-13L."

The new generated imaging lines have been added into the "Strain names" in the Materials and methods section.

> 2\) Crucial differences observed between the results described by Liu et al. and by Camacho et al., 2017 correspond to the measurements of the readily-releasable pool (RRP) of vesicles by treatment with hypertonic sucrose. It is unclear whether these are indeed real differences between the mammalian and worm systems, or the different results arise from differences in experimental protocols. For instance, the authors use 1 M sucrose instead of 500 mM sucrose, which is more common and was used by Camacho et al. It is also plausible that differences might arise from the method of application of sucrose. The authors should perform experiments with 500 mM sucrose to examine whether their results stand at this lower concentration, provide more experimental details on these experiments and discuss how experimental details might influence the results obtained. Raw traces for both concentrations should be provided and, when collecting the 500 mOsm data, the leak current for each trace used in the analysis should be noted.

Since Rosemund and colleagues first established the assay of using hypertonic sucrose-evoked synaptic current to estimate the size of the readily releasable vesicular pool (RRP), this assay has been widely used in both vertebrates and invertebrates. The sucrose concentrations and puffing durations, however, vary in different studies (Aravamudan et al., 1999; Richmond et al., 1999; Yoshihara and Littleton, 2002; Pang et al., 2006; Zhou et al., 2013). It is unlikely that the different results in SV priming in the *unc-10*(K77/79E) arise from the experimental protocols we used, as the large priming defect in the *unc-13* mutants has been consistently observed in our lab. Nevertheless, to address the reviewer's question, we compared the synaptic currents elicited by 0.5M sucrose between wild type and the *unc10(K77/79E)* mutants. To record a relatively stable sucrose response under this condition, a 5s puffing duration was used ([Author response image 1A, B](#respfig1){ref-type="fig"}). As shown in [Author response image 1](#respfig1){ref-type="fig"}, the charge transfer of the sucrose currents in the *unc-10(K77/79E)* mutants were comparable to those in wild-type worms ([Author response image 1C](#respfig1){ref-type="fig"}), consistent with the observation when using 1M sucrose. We have added these results in the main text. All the raw traces recorded in both 0.5M and 1M sucrose were shown in [Author response image 1A, B, D, E](#respfig1){ref-type="fig"}). These results confirmed the notion that disrupting the UNC-13L/RIM heterodimerization does not affect SV priming.

We have described more details how to perform the sucrose puff experiments at the worm NMJ in the "Materials and methods".

"A pulsed application of sucrose (1M, 2s) was applied onto the ventral nerve cord using a Picospritzer III (Parker). The glass pipette containing sucrose was placed at the end of the patched muscle (around half muscle distance from the recording pipette)."

"Nevertheless, we assessed the RRP size in the UNC-13L(K49E) rescue animals and the *unc10*(K77/79E) mutant by puffing hypertonic sucrose (1M, 2s). \[...\] The unchanged SV priming in the *unc-10*(K77/79E) mutant was also confirmed by puffing a lower concentration of sucrose (0.5M, 5s; data not shown)."
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\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The reviewers have discussed the reviews with one another and with the Reviewing Editor. They found most revisions satisfactory, but there are still some concerns that are summarized below to help you prepare a revised submission.
>
> 1\) The authors produced new extrachromasomal lines for the UNC-13 constructs tagged with C-terminal Apple, which allowed them to measure comparable expression levels, but these were not the arrays used to do the functional electrophysiological analysis in the paper. It is the case that arrays can vary in expression levels from one injection to the next. The authors only provide assurances that the behavior was rescued but did not show the data or the extent of the rescue. More concerning, they did not repeat the electrophysiological analyses on these strains. Without this, how can we be certain that these are similar to the original array-expressing strains and that the same results would be found.

Both mEPSCs and evoked EPSCs were analyzed in the *unc-13* mutants rescued by mApple-tagged UNC-13 proteins (UNC-13L, DC2A, and K49E). Basically, we found very similar results in these rescue strains, compared to those observed untagged UNC-13 rescue strains, indicating that the UNC-13 with C-terminal tag is fully functional. These results have been incorporated into the revised manuscript as a supplementary figure (Figure 4---figure supplement 1).

"All mApple-tagged UNC-13L constructs rescued the SV release in the *unc-13* mutants, and the phenotypes were similar to those rescued by corresponding untagged UNC13L constructs (Figure 4---figure supplement 1)"

> 2\) As for the hyperosmotic traces, only those for the unc-10(k77/79E) were reexamined in 0.5M sucrose and the requested leak currents for the two data sets (i.e. 0.5 and 1M) were not provided. The concern is that at 1M sucrose, if there were substantial leak, the large inward currents observed would arise not from sucrose-induced release but poor seals. This problem has arisen in the past in analyses of fly embryos in which large inward currents were observed in mutants that were subsequently shown to have no primed vesicles; the reason was leaky recordings. If the authors could have produced these data for the unc-13 null and the UNC-13 rescuing arrays tagged with Apple, this would have greatly improved confidence in the conclusions of the paper. The leak currents should be provided and the data should be interpreted considering these issues.

We now added the quantification for two more mutants, *unc-13(s69)* and UNC-13L rescue, under the lower sucrose condition (0.5M, 5s). The results are similar with what we obtained when puffing 1M sucrose (see [Author response image 2](#respfig2){ref-type="fig"}). Moreover, Zhou et al. have shown that removing the C2A domain from UNC-13L does not cause a change in the RRP size measured by puffing 0.5M sucrose (Zhou et al., 2013, *eLife*), consistent with our findings in this study. We hope that the reviews can agree that our current protocol for sucrose puffing (1M, 2s) is reasonable.
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We remade the following figures with all sucrose traces. The leak current can be seen on each individual traces. We also quantified the leak current for all the sucrose recordings (1M, 2s). The results have been incorporated into the revised manuscript as a supplementary figure (Figure 3---figure supplement 1). As you can see, the leak current is controlled very well in our recordings. The averaged leak current for each genotype is between -20pA and -30pA.

"It should be noted that recording of the sucrose-evoked current requires a tight gigaohm seal between the recording pipette and the cell, as a loose seal often leads to an unreal current. We therefore analyzed the leak currents for each sucrose recordings. Our data showed that all recordings were controlled well with acceptable leak currents (Figure 3---figure supplement 1)."

> 3\) In the decision letter a critical discussion of the use of extrachromosomal-array-based expression was provided. Clearly, overexpression via this approach could mask effects that would become detectable with WT-like expression levels. This issue should be discussed briefly as a possible caveat.

We agree with this point and have discussed the issue of rescue using extrachromosomal arrays.

"It should be noted that all the UNC-13 transgenes in this study are extrachromosomal arrays, and that the UNC-13 proteins are overexpressed in these transgenic animals. The overexpression of UNC-13 may cause differential effects with wild-type expression of this protein. Despite this, our findings (e.g., DC2A) are similar with Zhou et al. results which were obtained from *unc-13* mutants rescued by single copy of UNC-13."
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